Market Overview
The North American cardiac monitoring market includes electrocardiogram (ECG) equipment, cardiac event monitors, mobile cardiac telemetry units, implantable loop recorders, and related software platforms for analyzing heart data. North America commands the largest share of the global cardiac monitoring industry, driven primarily by the United States, which accounts for the majority of regional revenue. Canada represents a smaller but growing segment of the market, supported by its universal healthcare system and increasing adoption of advanced cardiac technologies.
- •Market valued at approximately $24.7 billion in 2025 with a projected 4.4% annual growth rate
- •North America represents the dominant regional segment globally, with the U.S. driving most activity
- •No official government statistical agency publishes dedicated market size figures for this sector
Growth Drivers
Rising prevalence of cardiovascular conditions including arrhythmias, heart failure, and coronary artery disease is expanding the patient population requiring continuous or intermittent cardiac monitoring. The aging demographic across North America, particularly the growing cohort of adults over 65, significantly increases demand as cardiac events become more common with age. Technological advances in wearable sensors, wireless connectivity, and cloud-based data analytics have made cardiac monitoring more accessible and clinically actionable.
- •Growing elderly population with higher incidence of cardiac arrhythmias and heart failure
- •Expanding adoption of remote patient monitoring and telehealth services post-pandemic
- •Advances in wearable sensor technology and AI-driven cardiac data analysis platforms
Segmentation and Regional Analysis
The market spans multiple product categories including continuous cardiac monitors, event recorders, mobile cardiac telemetry, implantable loop recorders, and sophisticated ECG monitoring systems used in clinical and home settings. The United States dominates the regional landscape, supported by advanced healthcare infrastructure, favorable reimbursement policies, and high rates of private insurance coverage for cardiac monitoring services. Canada's market is smaller but growing steadily, with provincial health systems gradually expanding coverage for remote cardiac monitoring technologies.
- •U.S. accounts for the vast majority of North American market revenue, driven by advanced clinical infrastructure
- •Canada represents a smaller but expanding segment with increasing provincial support for remote monitoring
- •Segments range from hospital-based continuous monitors to consumer wearable devices and implantable solutions
Trends and Outlook
What are the recent trends and outlook?
Remote and ambulatory cardiac monitoring is expected to remain the fastest-growing segment as healthcare systems prioritize reducing hospital readmissions and enabling proactive chronic disease management. Artificial intelligence and machine learning algorithms are increasingly being integrated into monitoring platforms to improve arrhythmia detection accuracy and reduce false positive alerts. The expanding use of smart watches and consumer-grade wearable devices for basic cardiac screening is also creating new opportunities and challenges for traditional medical device manufacturers.
- •AI-enhanced cardiac monitoring platforms are improving diagnostic accuracy and reducing clinician workload
- •Consumer wearable devices are driving greater public awareness and preliminary screening for heart conditions
- •Telehealth integration and reimbursement policy changes will continue shaping market access and adoption rates
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.